NDC 55154-5035-06 - MiraLAX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-5035
- Requested NDC
- 55154-5035-06
- Package NDCs from labels
- 55154-5035-6, 55154-5035-06
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2025-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MiraLAX - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2025-11-07 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-5035-6 | MiraLAX | 6 in 1 BAG | POWDER, FOR SOLUTION | 6 | 17 | |
| 55154-5035-6 | MiraLAX | 17 g in 1 PACKET | POWDER, FOR SOLUTION | 17 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-5035 | MIRALAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [CARDINAL HEALTH 107, LLC] | 16 | Current NDC, Legacy NDC, 2 package rows | 20250305_1771d3bf-954d-49ea-b260-3d356e5dcfa5.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL 3350 | ACTIVE INGREDIENT | G2M7P15E5P | MIRALAX (POLYETHYLENE GLYCOL 3350) POWDER [CARDINAL HEALTH] | 4 | |
| POLYETHYLENE GLYCOL 3350 | ACTIVE MOIETY | G2M7P15E5P | MIRALAX (POLYETHYLENE GLYCOL 3350) POWDER [CARDINAL HEALTH] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 0858a914-4812-4e4d-82f8-ecf93d43ef3b | 2022-07-01 | Warnings | G2M7P15E5P |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 199d6173-3fad-49e4-88fe-bde7223ed4c3 | 2022-06-01 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol | POLYETHYLENE GLYCOL | BluePoint Laboratories | c4cae70c-68da-0bbc-e053-2a95a90a395a | 2021-09-20 | Warnings | G2M7P15E5P |
| signature care clearlax | POLYETHYLENE GLYCOL 3350 | Safeway | 91d2e780-2aae-411c-b7b3-820302f0f63e | 2021-05-13 | Warnings | 876193 G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 NF | POLYETHYLENE GLYCOL 3350 | SUNRISE PHARMACEUTICAL, INC | ce5197a1-2677-4ffb-aef2-9221b28ebd23 | 2020-01-22 | Warnings | 876193 G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.